TaiGen, HEC launch cross-strait newco for HCV combo

TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157) and the YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558) subsidiary of HEC Pharm Group (Dongguan, China)

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.